Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

Roche to buy bispecific antibody developer

Country: Switzerland

The Roche group is set to broaden its antibody technology holdings with the acquisition of the privately-owned Austrian company Dutalys GmbH which has a new bispecific antibody platform. The deal is valued at up to $489 million including milestones.

Read more

Merck Acquires OncoEthix of Switzerland

Country: United States

Merck & Co Inc has bolstered its oncology portfolio with the acquisition of the privately-held Swiss biotechnology company OncoEthix SA which has a BET bromodomain inhibitor in Phase 1b for the treatment of haematological malignancies and advanced solid tumours.

Read more

Kymab to lead Ebola consortium

Country: United Kingdom

Read more

EMA comments on experimental Ebola treatments

Country: United Kingdom

Read more

Index Ventures invests in Stealthyx

Country: United Kingdom

Read more

More management changes at Zealand

Country: Denmark

Read more

BerGenBio gets funding to treat drug resistant cancers

Country: Norway

Read more

Everolimus fails in new cancer indication

Country: Switzerland

Read more

Pfizer commits new resource to gene therapy

Country: United States

Read more

European partners in drug discovery deal with US firm

Country: United Kingdom

Read more

Meeting Report: partnerships help biopharma innovate

Country: France

Read more

Merck to acquire Cubist for $9.5 billion

Country: United States

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

Ethics panels need to keep pace with trial reform

CommentaryEthicsCommitteesNovDec2014.pdf

Highlights of the Nov-Dec 2014 MedNous issue

The Nov-Dec 2014 MedNous features:

Latest Mednous cover
  • Regenerative Medicine
    Interview with Douglas Melton
    on a stem-cell approach
    for treating diabetes
  • HTA Review
    Europe moves towards
    faster access
  • Commentary
    Ethics panels and EU trial reform
    by Angelika Joos and
    Fabien Peuvrelle
  • Public Policy
    Balance of power
    in pharma is shifting
  • Research Interview
    Fighting bacteria with
    phage therapy

The latest MedNous journal. Subscribe to download.

Recent Appointments